Complete your selection
Clinical Chemistry
Employing the long lasting experience with ACE activity on a broad range of clinical chemistry analysers BÜHLMANN is going on to expand the existing product line with either specialized niche products or new upcoming markers for routine applications.
The focus of BÜHLMANN will be always high quality as well as user friendly offers including complete reagent packages. This includes all necessary calibrators and controls together with CE marked protocols for the Clinical Chemistry analysers.
ACE activity is a valuable marker to assess the activity of the chronic disease Sarcoidosis. The Enzyme is released by epitheloid cells and its serum levels correlates significantly with the granuloma burden of the patient.
Cystatin C is an upcoming and more reliable marker for glomerular filtration rate (GFR) assessment than the widely used method with creatinine.
GHB well known as liquid ecstasy is voluntary consumed not only by partygoers: It is increasingly used to substitute more expensive drugs. Furthermore GHB is administered on the sly to daze people in order to rape or rob them (k.o. drops).
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Search
News
NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND
BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb more
New Seegene DPO Movie showing how this unique and proprietary technology is working to allow innovative multiplexing.
The unique and proprietary DPO™(Dual-Priming-Oligonucleotide) technology is the corner stone for all of the Seegene products, and it is the key to achieve more
New EntroGen BRAF test (V600E/K/D) for the detection of important mutations found in melanoma on your real-time PCR instrument.
EntroGen has a new BRAF test that detects, beside the V600E mutation, also the V600K and the V600D, which are important mutations found in melanoma. more
BÜHLMANN innovations and news at the JIB
At the JIB Congress in Paris, 8th – 10th November 2011, BÜHLMANN presents the MDx products of EntroGen and AutoGenomics as well as new developments of its more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |
